Dr. Azarnoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
610 Edgewood Drive
Rio Vista, CA 94571Phone+1 707-374-2715- Is this information wrong?
Education & Training
University of Kansas School of MedicineClass of 1955
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1978
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- 12 citationsDrug interactions: clinical significance.Daniel L. Azarnoff
Clinical Pharmacology and Therapeutics. 1974-11-01 - 53 citationsPharmacokinetics of 1-beta-D-arabinofuranosylcytosine in humans.Suk Han Wan, David H. Huffman, Daniel L. Azarnoff, Barth Hoogstraten, William E. Larsen
Cancer Research. 1974-02-01 - 3 citationsPharmacokinetics, cortisol release, and hemodynamics after intravenous and subcutaneous injection of human corticotropin-releasing factor in humansMartin S. Angst, J. B. Dyck, Daniel L. Azarnoff, Ronald Goldblum, Bert Ho
Clinical Pharmacology and Therapeutics. 1998-11-01
Press Mentions
Toxicology and Tributaries in TexasFebruary 22nd, 2018
Dr. Daniel Azarnoff Recognized for Achievements in Pharmacology and EducationNovember 22nd, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
